ENDP
Price:
$0.3744
Market Cap:
$0
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or abs...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2014-03-03
Stock Exchange
NASDAQ
Ticker
ENDP
According to Endo International plc’s latest financial reports and current stock price. The company's current ROE is 60.16%. This represents a change of 91.04% compared to the average of 31.49% of the last 4 quarters.
The mean historical ROE of Endo International plc over the last ten years is -52.53%. The current 60.16% ROE has changed -214.53% with respect to the historical average. Over the past ten years (40 quarters), ENDP's ROE was at its highest in in the March 2018 quarter at 7.13%. The ROE was at its lowest in in the June 2017 quarter at -172.60%.
Average
-52.53%
Median
-29.38%
Minimum
-419.78%
Maximum
207.00%
Discovering the peaks and valleys of Endo International plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 394.56%
Maximum Annual ROE = 207.00%
Minimum Annual Increase = -827.42%
Minimum Annual ROE = -419.78%
Year | ROE | Change |
---|---|---|
2021 | 45.75% | -261.14% |
2020 | -28.39% | -158.21% |
2019 | 48.77% | -76.44% |
2018 | 207.00% | -149.31% |
2017 | -419.78% | 238.83% |
2016 | -123.89% | 394.56% |
2015 | -25.05% | -17.53% |
2014 | -30.37% | -76.69% |
2013 | -130.29% | 88.81% |
2012 | -69.01% | -827.42% |
The current ROE of Endo International plc (ENDP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.04%
5-year avg
-29.33%
10-year avg
-52.53%
Endo International plc’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Endo International plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Endo International plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Endo International plc's ROE?
How is the ROE calculated for Endo International plc (ENDP)?
What is the highest ROE for Endo International plc (ENDP)?
What is the 3-year average ROE for Endo International plc (ENDP)?
What is the 5-year average ROE for Endo International plc (ENDP)?
How does the current ROE for Endo International plc (ENDP) compare to its historical average?